SPONSOR
Essen Biotech
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2
Conditions studied: Pancreatic CancerPancreatic CarcinomaPancreatic Cancer Non-resectablePancreatic Cancer Stage IVAMLAcute Myeloid LeukemiaAML, Adult RecurrentAML, AdultBrain TumorBrain Metastases
Essen Biotech is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Pancreatic Cancer, Pancreatic Carcinoma, Pancreatic Cancer Non-resectable, Pancreatic Cancer Stage IV.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Essen Biotech
How many clinical trials has Essen Biotech sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Essen Biotech, of which 3 are actively recruiting participants. These trials cover conditions including Pancreatic Cancer, Pancreatic Carcinoma, Pancreatic Cancer Non-resectable. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Essen Biotech research focus on?
Essen Biotech clinical trials span Pancreatic Cancer, Pancreatic Carcinoma, Pancreatic Cancer Non-resectable, Pancreatic Cancer Stage IV, AML, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Essen Biotech clinical trial?
To participate in a Essen Biotech trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Essen Biotech trials with current recruitment status updated daily.
Clinical Trials by Essen Biotech
NCT07066995 Phase 1, Phase 2
Recruiting
Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer
Pancreatic Cancer
NCT06420063 Phase 1, Phase 2
Recruiting
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
AML
NCT06640582 Phase 1, Phase 2
Recruiting
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Brain Tumor
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology